Literature DB >> 28055182

Arylsulfatase K is the Lysosomal 2-Sulfoglucuronate Sulfatase.

Omkar P Dhamale1, Roger Lawrence2, Elena M Wiegmann3, Bhahwal A Shah1, Kanar Al-Mafraji1, William C Lamanna2, Torben Lübke3, Thomas Dierks3, Geert-Jan Boons1,4, Jeffrey D Esko2.   

Abstract

The degradation of glycosaminoglycans (GAGs) involves a series of exolytic glycosidases and sulfatases that act sequentially on the nonreducing end of the polysaccharide chain. Enzymes have been cloned that catalyze all of the known linkages with the exception of the removal of the 2-O-sulfate group from 2-sulfoglucuronate, which is found in heparan sulfate and dermatan sulfate. Here, we show using synthetic disaccharide substrates that arylsulfatase K is the glucuronate-2-sulfatase. Arylsulfatase K acts selectively on 2-sulfoglucuronate and lacks activity against 2-sulfoiduronate, whereas iduronate-2-sulfatase (IDS) desulfates synthetic disaccharides containing 2-sulfoiduronate but not 2-sulfoglucuronate. As arylsulfatase K has all of the properties expected of a lysosomal enzyme, we conclude that arylsulfatase K is the long sought lysosomal glucuronate-2-sulfatase, which we designate GDS.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28055182      PMCID: PMC6031138          DOI: 10.1021/acschembio.6b01033

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  26 in total

1.  Molecular cloning and initial characterization of three novel human sulfatases.

Authors:  Alvaro J Obaya
Journal:  Gene       Date:  2006-02-24       Impact factor: 3.688

Review 2.  The molecular diversity of glycosaminoglycans shapes animal development.

Authors:  Hannes E Bülow; Oliver Hobert
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

Review 3.  Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility.

Authors:  Sarah R Hanson; Michael D Best; Chi-Huey Wong
Journal:  Angew Chem Int Ed Engl       Date:  2004-11-05       Impact factor: 15.336

4.  Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.

Authors:  Roger Lawrence; Sara K Olson; Robert E Steele; Lianchun Wang; Rahul Warrior; Richard D Cummings; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

5.  Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.

Authors:  Sailaja Arungundram; Kanar Al-Mafraji; Jinkeng Asong; Franklin E Leach; I Jonathan Amster; Andre Venot; Jeremy E Turnbull; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

6.  A sulfatase specific for glucuronic acid 2-sulfate residues in glycosaminoglycans.

Authors:  P N Shaklee; J H Glaser; H E Conrad
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

7.  Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme.

Authors:  Thomas Dierks; Bernhard Schmidt; Ljudmila V Borissenko; Jianhe Peng; Andrea Preusser; Malaiyalam Mariappan; Kurt von Figura
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

8.  Arylsulfatase K, a novel lysosomal sulfatase.

Authors:  Elena Marie Wiegmann; Eva Westendorf; Ina Kalus; Thomas H Pringle; Torben Lübke; Thomas Dierks
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

9.  Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses.

Authors:  Roger Lawrence; Jillian R Brown; Kanar Al-Mafraji; William C Lamanna; James R Beitel; Geert-Jan Boons; Jeffrey D Esko; Brett E Crawford
Journal:  Nat Chem Biol       Date:  2012-01-08       Impact factor: 15.040

10.  The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases.

Authors:  Maria Pia Cosma; Stefano Pepe; Ida Annunziata; Robert F Newbold; Markus Grompe; Giancarlo Parenti; Andrea Ballabio
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

View more
  4 in total

1.  Complex care of individuals with multiple sulfatase deficiency: Clinical cases and consensus statement.

Authors:  Rebecca Ahrens-Nicklas; Lars Schlotawa; Andrea Ballabio; Nicola Brunetti-Pierri; Mauricio De Castro; Thomas Dierks; Florian Eichler; Can Ficicioglu; Alan Finglas; Jutta Gaertner; Brian Kirmse; Joerg Klepper; Marcus Lee; Amber Olsen; Giancarlo Parenti; Arastoo Vossough; Adeline Vanderver; Laura A Adang
Journal:  Mol Genet Metab       Date:  2018-01-31       Impact factor: 4.797

2.  Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate.

Authors:  Christof Trabszo; Bastian Ramms; Pradeep Chopra; Renate Lüllmann-Rauch; Stijn Stroobants; Jens Sproß; Anke Jeschke; Thorsten Schinke; Geert-Jan Boons; Jeffrey D Esko; Torben Lübke; Thomas Dierks
Journal:  Biochem J       Date:  2020-09-18       Impact factor: 3.857

3.  Novel subtype of mucopolysaccharidosis caused by arylsulfatase K (ARSK) deficiency.

Authors:  Sarah Verheyen; Jasmin Blatterer; Michael R Speicher; Gandham SriLakshmi Bhavani; Geert-Jan Boons; Mai-Britt Ilse; Dominik Andrae; Jens Sproß; Frédéric Maxime Vaz; Susanne G Kircher; Laura Posch-Pertl; Daniela Baumgartner; Torben Lübke; Hitesh Shah; Ali Al Kaissi; Katta M Girisha; Barbara Plecko
Journal:  J Med Genet       Date:  2021-12-16       Impact factor: 5.941

4.  A click-flipped enzyme substrate boosts the performance of the diagnostic screening for Hunter syndrome.

Authors:  Markus Schwarz; Philipp Skrinjar; Michael J Fink; Stefan Kronister; Thomas Mechtler; Panagiotis I Koukos; Alexandre M J J Bonvin; David C Kasper; Hannes Mikula
Journal:  Chem Sci       Date:  2020-10-23       Impact factor: 9.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.